2019
DOI: 10.1111/jcmm.14336
|View full text |Cite
|
Sign up to set email alerts
|

Coronary circulating mononuclear progenitor cells and soluble biomarkers in the cardiovascular prognosis after coronary angioplasty

Abstract: Currently, there are no confident prognostic markers in patients with coronary artery disease (CAD) undergoing angioplasty. The present study aimed to explore whether basal coronary circulating Mononuclear Progenitor Cells (MPCs) and vascular injury biomarkers were related to development of major adverse cardiovascular events (MACEs) and may impact clinical prognosis. Methods The number of MPCs and soluble mediators such as IL‐1β, sICAM‐1, MMP‐9, malondialdehyde, superoxide dismutas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Consequently, advanced HF and progression of AMI-induced adverse cardiac remodelling were related to impaired vascular repair, vascularization, and angiogenesis due to a declined number of circulating precursors and lowered their function and survival [222]. This phenomenon is known as progenitor cell dysfunction and considered a promising predictive biomarker for CV mortality and HF progression and admission [223,224], as well as in patient population with AMI submitted to PCI [225]. Probably, coronary circulating proangiogenic MPCs/EPCs collected from coronary sinus in AMI patients with subsequent PCI can become a powerful biomarker with increased accuracy in the prediction of adverse cardiac remodelling.…”
Section: Circulating Mononuclear and Endothelial Progenitormentioning
confidence: 99%
“…Consequently, advanced HF and progression of AMI-induced adverse cardiac remodelling were related to impaired vascular repair, vascularization, and angiogenesis due to a declined number of circulating precursors and lowered their function and survival [222]. This phenomenon is known as progenitor cell dysfunction and considered a promising predictive biomarker for CV mortality and HF progression and admission [223,224], as well as in patient population with AMI submitted to PCI [225]. Probably, coronary circulating proangiogenic MPCs/EPCs collected from coronary sinus in AMI patients with subsequent PCI can become a powerful biomarker with increased accuracy in the prediction of adverse cardiac remodelling.…”
Section: Circulating Mononuclear and Endothelial Progenitormentioning
confidence: 99%
“…As coronary atherogenesis progresses, the atheroma plaque slowly grows within the coronary artery wall, along the local accumulation of a large amount of thrombogenic content, which eventually reduces the coronary lumen and limits myocardial oxygen supply [4]. Atherogenic progression depends on genetics and metabolic components, as well as local coronary factors, such as the release of pro-inflammatory and pro-atherogenic mediators [5,6]. In this context, pro-inflammatory cytokines IL-6, TNFα and IL1β have been particularly related with the atheroma plaque and CAD severity [7][8][9].…”
Section: Introductionmentioning
confidence: 99%